Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Reagent Red Cell Products Unveiled at Annual Blood Banking Meeting

By LabMedica International staff writers
Posted on 03 Nov 2014
Four new reagent red cell diagnostic products were unveiled at a blood banking meeting.

The annual meeting of the American Association of Blood Banks (AABB) that was held in Philadelphia, PA, USA from October 25–28, 2014, was selected for the launch of new red cell reagent diagnostic products produced by Quotient Limited (St Helier, Jersey).

The four new products are: (1) ALBAcyte Expanded Rh Negative Antibody Screen, (2) ALBAcyte Antibody Identification Panel (16-cell), (3) ALBAcyte Antibody Screen (two-cell), and (4) ALBAzyme Papain Solution Kit.

The ALBAcyte Expanded Rh Negative Antibody Screen will be of particular use with pregnant, Rh-negative women who have been treated with Rh immunoglobulin. More...
Its Rh-negative cells detect all the unexpected antibodies required of traditional screens. The ALBAcyte Antibody Identification Panel (16-cell) is a full antibody identification panel with six complementary cells. The ALBAcyte Antibody Screen (two-cell) is a robust antibody screen for those laboratories that prefer a two-cell screen, or frequently test pediatric or other small-volume samples. Red cells incorporated in this product have been carefully selected to maximize homozygosity, thus optimizing the detection of antibodies. The ALBAzyme Papain Solution Kit is a kit combining both papain and enzyme control, which pairs with the existing papain-treated ALBAcyte Antibody Identification Panel (10-cell), to better allow laboratories to treat and test auto-controls and patient samples.

"These four new products expand our reagent red cell offering, including the addition of a number of novel products," said Jeremy Stackawitz, president of Quotient Limited. "Quotient's product offering can now address all the needs of the vast majority of blood bank laboratories, truly making it a one-stop-shop for reagent red cells."

Related Links:
Quotient Limited



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.